Opinion/decision on a Paediatric investigation plan (PIP): Tezspire, tezepelumab, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Gastroentology-Hepatology, PIP number: P

Opinion/decision on a Paediatric investigation plan (PIP): Tezspire, tezepelumab, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Gastroentology-Hepatology, PIP number: P/0407/2023

Orphan designation: adeno-associated virus vector serotype SAN011 encoding a microRNA against DMPK mRNA Treatment of dystrophic myotonia type 1, 11/10/2024 Positive

Orphan designation: adeno-associated virus vector serotype SAN011 encoding a microRNA against DMPK mRNA Treatment of dystrophic myotonia type 1, 11/10/2024 Positive

Informative webinar on PMS Product User Interface usage and key actions for Marketing Authorisation Holders (with demo), Online, Amsterdam, the Netherlands, from 29 October 2024, 10:00 (CET) to 29 October 2024, 12:00 (CET)

Informative webinar on PMS Product User Interface usage and key actions for Marketing Authorisation Holders (with demo), Online, Amsterdam, the Netherlands, from 29 October 2024, 10:00 (CET) to 29 October 2024, 12:00 (CET)

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness